Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling cell-cell interactions to advance drug discovery in Idiopathic Pulmonary Fibrosis.

bioRxiv : the preprint server for biology·2026
Same author

Bidirectional fibrogenic cross-talk revealed in a human iPSC-derived epithelial-mesenchymal co-culture model of pulmonary fibrosis.

bioRxiv : the preprint server for biology·2026
Same author

MI-181 enhances ciliation and cilia length in a cigarette smoke exposed airway epithelial model.

Scientific reports·2026
Same author

Protocol for constructing an accessible exposure chamber for in vitro and in vivo modeling of airway environmental exposures.

STAR protocols·2025
Same author

Unflavored electronic cigarette exposure induces alterations in airway ciliary structure and function.

Respiratory research·2025
Same author

Open Source Repurposing Reveals Broad-Spectrum Antiviral Activity of Diphenylureas.

Viruses·2025

Related Experiment Video

Updated: Jul 14, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

Fibrocytes in lung disease.

Brigitte N Gomperts1, Robert M Strieter

  • 1Mattel Children's Hospital, Department of Pediatrics, Division of Pediatric Hematology Oncology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA.

Journal of Leukocyte Biology
|June 7, 2007
PubMed
Summary

Fibrocytes, bone marrow-derived cells involved in tissue repair and fibrosis, express leukocyte and mesenchymal markers. This review details their role in lung diseases like pulmonary fibrosis and asthma.

Related Experiment Videos

Last Updated: Jul 14, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

Area of Science:

  • Cellular and Molecular Biology
  • Immunology
  • Pulmonology

Background:

  • Fibrocytes are circulating cells with fibroblast-like properties, originating from bone marrow.
  • They play a crucial role in tissue repair, wound healing, and the development of fibrosis.
  • Understanding fibrocyte function is key to addressing fibrotic diseases.

Purpose of the Study:

  • To review the current knowledge on fibrocytes, focusing on their characteristics and functions.
  • To explore the involvement of fibrocytes in various fibrotic disorders.
  • Specifically, to examine their contribution to lung diseases such as pulmonary fibrosis, asthma, and vascular remodeling.

Main Methods:

  • Review of existing scientific literature on fibrocytes.
  • Analysis of cellular markers (leukocyte and mesenchymal) expressed by fibrocytes.
  • Examination of chemokine receptor expression (CXCR4, CCR7) and its role in cell trafficking.

Main Results:

  • Fibrocytes express key leukocyte markers (CD34, CD45, CD13) and mesenchymal markers (pro-collagens I and III, vimentin, fibronectin).
  • Chemokine receptors CXCR4 and CCR7 are expressed, facilitating migration from circulation to tissues.
  • Fibrocytes are implicated in the pathogenesis of several fibrotic conditions.

Conclusions:

  • Fibrocytes are significant contributors to wound healing and fibrotic processes.
  • Their unique marker profile and migratory capacity underscore their importance in disease.
  • This review highlights the critical role of fibrocytes in lung diseases, necessitating further research for therapeutic strategies.